Structure-activity relationship study of 2,4-diaminothiazoles as Cdk5/p25 kinase inhibitors.
about
Development of Highly Potent and Selective Diaminothiazole Inhibitors of Cyclin-Dependent KinasesDiscovery of thienoquinolone derivatives as selective and ATP non-competitive CDK5/p25 inhibitors by structure-based virtual screeningFrom on-target to off-target activity: identification and optimisation of Trypanosoma brucei GSK3 inhibitors and their characterisation as anti-Trypanosoma brucei drug discovery lead molecules.Diaminothiazoles modify Tau phosphorylation and improve the tauopathy in mouse modelsApproaches to efficiently estimate solvation and explicit water energetics in ligand binding: the use of WaterMap.Drug discovery and human African trypanosomiasis: a disease less neglected?Determination of kinetic parameters and structure-activity relationships of ginsenosides as inhibitors of cyclin-dependent kinase 5/p25 using ultra-pressure liquid chromatography with triple quadrupole tandem mass spectrometry.Consensus models for CDK5 inhibitors in silico and their application to inhibitor discovery.Several human cyclin-dependent kinase inhibitors, structurally related to roscovitine, are new anti-malarial agents.
P2860
Q27677453-FCBAB54E-0919-4F4F-AEDC-1990A67200CDQ34625383-706863B6-4D68-45DD-AC6D-4911D264E24FQ34775438-06D02771-71E5-49A9-AD15-D5799B962270Q37048487-E830CBE2-2C74-4709-8027-09F7A402BB34Q38071408-EA1478E9-4E2C-4F92-8A4A-2C08D536642FQ38154344-5D57142E-DD81-45B3-B8DE-62C19A03E602Q43868561-643D7402-99C5-4679-974B-7FE682ED49B3Q45955634-94C9DC42-B0BB-457E-8666-CE23E4CAC242Q47884524-C5520A34-42E2-4850-84F8-3CF8BEC7285F
P2860
Structure-activity relationship study of 2,4-diaminothiazoles as Cdk5/p25 kinase inhibitors.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Structure-activity relationshi ...... as Cdk5/p25 kinase inhibitors.
@ast
Structure-activity relationshi ...... as Cdk5/p25 kinase inhibitors.
@en
Structure-activity relationshi ...... as Cdk5/p25 kinase inhibitors.
@nl
type
label
Structure-activity relationshi ...... as Cdk5/p25 kinase inhibitors.
@ast
Structure-activity relationshi ...... as Cdk5/p25 kinase inhibitors.
@en
Structure-activity relationshi ...... as Cdk5/p25 kinase inhibitors.
@nl
prefLabel
Structure-activity relationshi ...... as Cdk5/p25 kinase inhibitors.
@ast
Structure-activity relationshi ...... as Cdk5/p25 kinase inhibitors.
@en
Structure-activity relationshi ...... as Cdk5/p25 kinase inhibitors.
@nl
P2093
P2860
P1476
Structure-activity relationshi ...... as Cdk5/p25 kinase inhibitors.
@en
P2093
Gregory D Cuny
Joydev K Laha
Kenneth S Kosik
Lixin Qiao
Shaughnessy Robinson
Snigdha Chatterjee
Xuemei Zhang
P2860
P304
P356
10.1016/J.BMCL.2011.01.140
P407
P577
2011-02-03T00:00:00Z